The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
A novel tyrosine kinase inhibitor PTK787/ZK222584
Author(s): 
Pages: 579-582
Year: Issue:  8
Journal: JOURNAL OF INTERNATIONAL ONCOLOGY

Keyword:  受体蛋白质酪氨酸激酶类血管生成抑制剂受体血管内皮生长因子肿瘤;
Abstract: PTK787/ZK222584是一种新型血管内皮生长因子受体酪氨酸激酶抑制剂,通过抑制酪氨酸激酶的磷酸化,阻断信号传导,抑制肿瘤新生血管的形成从而抑制肿瘤的生长.临床前研究和临床试验研究显示该药对多种肿瘤有抗肿瘤活性,不良反应较轻.
Related Articles
loading...